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 Summary
 Background: Restricted diffusion that is found on magnetic resonance diffusion-weighted imaging (DWI) 
typically indicates acute ischaemic stroke. However, restricted diffusion can also occur in other 
diseases, like metastatic brain tumours, which we describe in this case report.
 Case Report: A 57-year-old male, with a diagnosis of small-cell cancer of the right lung (microcellular anaplastic 
carcinoma), was admitted with focal neurological symptoms. Initial brain MRI revealed multiple, 
disseminated lesions that were hyperintense on T2-weighted images and did not enhance after 
contrast administration; notably, some lesions manifested restricted diffusion on DWI images. 
Based on these findings, disseminated ischaemic lesions were diagnosed. On follow-up MRI that 
was performed after 2 weeks, we observed enlargement of the lesions; there were multiple, 
disseminated, sharply outlined, contrast-enhancing, oval foci with persistent restriction of 
diffusion. We diagnosed the lesions as disseminated brain metastases due to lung cancer. To our 
knowledge, this is the first description of a patient with brain metastases that were characterised 
by restricted diffusion and no contrast enhancement.
 Conclusions: Multiple, disseminated brain lesions, that are characterised by restricted diffusion on DWI, 
typically indicate acute or hyperacute ischemic infarcts; however, they can also be due to 
hypercellular metastases, even if no contrast enhancement is observed. This latter possibility 
should be considered particularly in patients with cancer.
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Diffusion weighted imaging (DWI) is based on an analysis 
of diffusion of water molecules (the so-called Brownian 
motion) [1,2]. On DWI, areas that are characterised by nor-
mal diffusion of water are iso- or hypointense. On DWI, 
restriction of diffusion is observed as hyperintense sig-
nal, whereas a corresponding signal attenuation is seen in 
apparent diffusion coefficient (ADC) maps. Moreover, ADC 
maps allow for a quantitative analysis of true values of dif-
fusion coefficients [2].
Differential diagnosis of disseminated brain lesions that 
are characterised by restricted diffusion includes primar-
ily acute or hyperacute ischaemic infarcts, multiple bacte-
rial abscesses, demyelinating lesions in multiple sclerosis 
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patients, and various forms of primary central nervous 
lymphomas (PCNSL) [1–3]. In general, cerebral metastases 
do not display restricted diffusion or the decline in signal 
on ADC maps [4]; in contrast, cerebral metastases could 
display increased diffusion with preserved or increased 
signal on ADC maps, if they are cystic or necrotic [1,2,5]. 
However, cases of cerebral metastases that were char-
acterised by DWI hyperintensities with corresponding 
ADC hypointensities have been described [5,6]. Because 
such radiological features suggest disseminated ischem-
ic infarcts, they constitute an important clinical issue. 
Cases of cerebral metastases with restriction of diffusion 
described to date occurred in patients with lung cancer, 
breast cancer, colon cancer, testicular cancer, and renal 
cancer [6–8]. Therefore, cerebral metastases should be 
included in the differential diagnosis of disseminated cer-
ebral lesions that display restricted diffusion on DWI, espe-
cially in patients with a history of cancer.
We describe a patient with small-cell lung cancer who had 
disseminated cerebral lesions that were characterised by 
DWI hyperintensities and lack of the contrast enhance-
ment. Based on conventional MRI with DWI sequence, 
these lesions were initially diagnosed as disseminat-
ed ischaemic lesions, and later turned out to be cerebral 
metastases.
Case Report
A 53-year-old man, with a history of hypertension and 
small-cell cancer of the right lung (pathologically anaplas-
tic microcellular carcinoma) that was diagnosed 2 months 
earlier and treated palliatively with etoposide and cispl-
atin, was admitted because of a clonic seizure in the right 
extremities that occurred one day before.
On admission, the following neurological signs were pre-
sent: slight facial asymmetry to the right, slight weakness 
of the right upper extremity, and slight ataxia on finger-to-
nose testing; all signs were present throughout hospitali-
sation. Moreover, we observed clonic seizures of the right 
extremities that were successfully treated with intrave-
nous clonazepam.
On contrast-enhanced haed computed tomography (CT) 
that was performed in the day of admission, we observed 
hyperdense foci in the frontal and parietal cortex on the 
left that did not enhance after contrast administration. 
They were interpreted as calcifications or haemorrhagic 
strokes (Figure 1).
On brain MRI that was performed two days later, there 
were small, disseminated, T2 and FLAIR hyperintensities in 
the bilateral parieto-frontal areas, left temporal area, bilat-
eral occipital areas, left thalamus, and lenticular nucle-
us. The lesions did not show contrast enhancement, and 
there was no oedema around them. Most lesions displayed 
restricted diffusion on DWI. Taken together, such radiologi-
cal features indicated the presence of multiple acute and 
subacute ischaemic lesions (Figure 2).
Doppler carotid ultrasound and echocardiography did not 
show any abnormalities that could be responsible for for-
mation of thromboembolic material.
On brain MRI that was performed on the 16th day since 
symptom onset, there was enlargement of the lesions and 
persistence of restricted diffusion in the lesions in the cer-
ebral cortex and basal ganglia. Moreover, contrast enhance-
ment was observed in multiple, disseminated, well-deline-
ated, oval lesions in the cerebral cortex of both brain hemi-
spheres, pineal gland, and pons; there was no oedema around 
the lesions. Because a typical evolution of ischaemic lesions 
in DWI sequences was not observed, contrast enhancement 
in multiple lesions was observed, and the patient had lung 
cancer, we diagnosed cerebral metastases (Figure 3).
Discussion
Restricted diffusion on DWI is observed primarily in acute 
or hyperacute ischaemic infarcts, abscesses, and in cer-
tain hypercellular brain tumours. In ischaemic stroke, 
Figure 1.  Brain CT performed after one day since onset of neurological symptoms: (A) before and (B) after contrast administration. A hyperdense 
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Figure 2.  Brain MRI performed after 4 days since onset of neurological symptoms; before contrast administration: (A) T1-weighted, (B) T2-
weighted, (C) FLAIR, (D) DWI-EPI, (E) ADC map images; (F) T1-weighted axial images after contrast administration. On T2-weighted and 
FLAIR images, a hyperintense lesion can be observed in the left parietal cortex; the lesion displays features of restricted diffusion, signal 







Figure 3.  Brain MRI perforemed sixteen days since onset of neurological symptoms; before contrast administration: (A) T1-weighted, (B) T2-
weighted, (C) FLAIR, (D) DWI-EPI, and (E) ADC map images; (F) T1-weighted axial image after administration of contrast. On T2-weighted 
and FLAIR images, hyperintense foci can be observed in the left parietal cortex, together with new foci in the right frontal cortex and 
both parietal regions. On DWI, restricted diffusion is seen in both brain hemispheres. Signal intensity of the described lesions increased 
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restriction of diffusion is due to cytotoxic oedema that 
leads to shrinkage of the extracellular space [1,9,10]. A rela-
tive restriction of diffusion, that is observed in abscesses, 
likely results from an increased density of abscess contents 
that include active and necrotic neutrophils, bacteria, and 
necrotic tissue, all of which inhibit diffusion of water mol-
ecules [1,7]. Most of demyelinating lesions in multiple scle-
rosis are characterised by increased ADC values, although 
certain acute demyelinating lesions can display restric-
tion of diffusion with a corresponding decrease in signal 
in ADC maps. This finding is explained by a hypothetical 
presence of cytotoxic oedema in the myelin sheath, which 
can inhibit diffusion of water molecules in the extracellular 
space [11].
Primary brain tumours that display restricted diffusion 
include lymphomas [3], medulloblastoma [12], and high-
grade gliomas (especially glioblastoma multiforme) [13]. It 
is suspected that restriction of diffusion that is observed 
in primary brain tumours is caused by hypercellu-
lar areas (i.e., areas with high cellular indices) [13–16] in 
which shrinkage of extracellular space impedes diffusion 
of water. Other potential causes of restricted diffusion 
in primary brain tumours include bacterial superinfec-
tion [17] and post-radiation tissue necrosis [18]. Also, one 
should be aware of the T2 shine-through effect that is relat-
ed to T2-dependent components in DWI maps. Notably, 
this effect can be verified when DWI are compared with 
ADC maps, since only true restriction of diffusion causes 
decreased ADC values [2,5].
Restriction of diffusion that is observed in cerebral metas-
tases could result from a high nuclear-cytoplasmic ratio 
with relative hypercellularity of cancer cells [5], liquefac-
tive necrosis [7,18], and haemorrhage [19]. These factors 
could impede diffusion of water molecules in the extracel-
lular space, thereby leading to typical findings on DWI and 
ADC maps [5].
A potential relationship between primary tumour cell type 
and presence of cerebral metastases that are characterised 
by restricted diffusion has been studied by some authors. 
Duygulu et al., in a study involving 76 patients, did not 
determine any significant relation between the cell type 
of primary tumours and presence of cerebral metastases 
displaying restriction of diffusion. However, those authors 
noted that cerebral metastases with restricted diffusion 
were observed primarily in patients with lung cancer 
(small-cell and non-small-cell carcinoma) or breast cancer. 
Moreover, 15 patients with colon cancer and prostate can-
cer also presented with cerebral metastases that displayed 
restricted diffusion [6].
In the study by Geijer et al., among 12 patients with cer-
ebral metastases originating from various tumours, one 
patient with small-cell lung cancer had multiple lesions 
that suggested lacunar ischaemic infarcts on T2, T1, con-
trast-enhanced, DWI, and ADC sequences; in that patient, 
only a large number of lesions that were found throughout 
the brain indicated an alternative diagnosis. In the same 
study, half of patients had lung cancer (small-cell, non-
small-cell, squamous cell carcinoma, and adenocarcino-
ma), and all cerebral metastases that originated from lung 
cancer were characterised by restricted diffusion and ring 
enhancement [8].
Based on the available literature [5,7,8,18], characteristic 
features of cerebral metastases, that are observed on CT 
and MRI, include distinct contrast enhancement that can 
be rim-like, tuberous, or homogenous [20]. These features 
differentiate cerebral metastases from subacute ischaemic 
infarcts in which contrast enhancement is seen on the bor-
ders of ischaemic foci, along the cerebral cortex (so-called 
luxury perfusion).
The fact that our patient had cerebral metastases that 
did not display contrast enhancement on initial MRI is 
exceptional. To the best of our knowledge, this is the first 
described case of cerebral metastases that were character-
ised by restricted diffusion and lack of contrast enhance-
ment. Based on previous studies [21–24], we suppose that 
this was due to the fact that the blood-brain barrier was 
intact during the initial MRI examination, which prevent-
ed extravasation of contrast into the metastases. Another 
potential mechanism could involve a protective role of 
chemotherapeutics that were initially able to maintain the 
integrity of the blood-brain barrier [22]. Within two weeks, 
neoangiogenesis could contribute to disruption of the 
blood-brain barrier, which in turn could lead to extravasa-
tion of contrast material, as observed on the follow-up MRI 
examination in our patient. This hypothesis can be sup-
ported by case reports of patients who were treated with 
bevacizumab, an inhibitor of angiogenesis. Namely, in these 
patients, a decrease in or lack of contrast enhancement was 
observed in cerebral metastases, which was accompanied 
by reduction of vasogenic oedema [25]. Moreover, discon-
tinuation of bevacizumab led to more pronounced contrast 
enhancement and oedema [26]. Differential diagnosis in our 
patient was difficult due to lack of vasogenic oedema that 
is usually found on T2 and FLAIR images; moreover, vaso-
genic oedema is characterised by facilitated diffusion on 
DWI [7]. To date, several cases of metastases that were not 
accompanied by oedema have been reported [21,27], which 
was explained by preservation of the blood-brain barrier at 
the early stage of the process of metastasizing.
An overlap between metastatic and ischaemic lesions can 
further hamper diagnosis. Cerebral metastases can occur 
in any part of the brain, but they tend to localise preferen-
tially at sites typical for lacunar infarcts, such as the bor-
der between white and grey matter, basal ganglia, thala-
mus, and centrum semiovale [8,28,29]. Although most of 
the cerebral metastases that were observed in our patient 
were found in the cerebral cortex, which is atypical, simi-
lar metastases with a histopathological confirmation have 
been described in other reports [21,23].
It is worth to name other advanced MRI techniques that 
could improve the differential diagnosis of dissemi-
nated lesions that are characterised by restriction of dif-
fusion. Magnetic resonance spectroscopy (MRS) shows 
an increased Cho/Cr, decreased NAA/Cr, and no change 
in ml/Cr ratios in the solid part of metastases that are 
enhancing following contrast administration [4,24,30–32]. 
Moreover, peaks of lactic acid and lipids can be seen in 
necrotic metastases [4]. As regards non-enhancing regions 
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of metastases, MRS spectra should be similar to those for 
the white matter [31,32]. According to the study by Lin et 
al., in the centre of acute ischemic brain infarcts, one can 
observe decreased NAA/Cr and NAA/Cho ratios, as com-
pared to the healthy brain hemisphere; moreover, the peak 
of lactic acid increases within 12 hours [33]. Due to an 
overlap of MRS spectra between cerebral metastases and 
ischaemic infarcts, MRS is not sufficient to differentiate 
between these diagnoses.
On perfusion-weighted imaging (PWI), cerebral metastases, 
having a rich vascular supply, display high relative cerebral 
blood volumes (rCBV), as compared to contralateral white 
matter [31,34–36]. Because hyperacute, acute, and subacute 
cerebral infracts are characterised by decreased rCBV, PWI 
can help differentiate between metastases and ischaemic 
infarcts.
Conclusions
Disseminated and non-contrast enhancing cerebral lesions 
with restricted diffusion on DWI typically character-
ise hyperacute and acute ischaemic infarcts, but they can 
also indicate hypercellular metastases. This latter possi-
bility should be taken into account especially in patients 
with a history of cancer. If initial MRI in these patients 
reveals disseminated T2 and FLAIR hyperintensities with 
no contrast enhancement, follow-up imaging should be 
performed, as the blood-brain barrier can disrupt due to 
cancer progression, which can be visualized as contrast 
enhancement. This approach will help make correct diag-
noses. In doubtful cases, PWI and other advanced MRI 
techniques can be employed.
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